Fischer reports strong third quarter

Article

X-ray equipment manufacturer Fischer Imaging experienced recordrevenues and improved earnings in the third quarter (end-October). The Denver company's revenues totaled $19.1 million, a jump of23% from third-quarter results a year ago, when Fischer had

X-ray equipment manufacturer Fischer Imaging experienced recordrevenues and improved earnings in the third quarter (end-October).

The Denver company's revenues totaled $19.1 million, a jump of23% from third-quarter results a year ago, when Fischer had salesof $15.5 million. The company reported earnings of $883,000 comparedto a loss of $4.7 million in the third quarter of 1994. Earningsadjustments last year included a $4.3 million write-down for adiscontinued product and other nonrecurring costs, according tothe company.

"Strong third-quarter results confirm our belief that effortsto reduce costs and improve our sales mix are taking hold,"said Morgan Nields, chairman and CEO.

The results occurred despite start-up costs relating to a newtilt-table interventional C-arm system and a 24% increase in R&Dspending, Nields noted.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.